(Q37621786)

English

The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy

scientific article published on 25 October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

1 reference

Europe PubMed Central

The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Masaru Taniguchi

1

object named as

Masaru Taniguchi

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

author name string

Takuya Tashiro

2

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Nyambayar Dashtsoodol

3

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Naomi Hongo

4

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Hiroshi Watarai

5

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

publication date

25 October 2009

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

International Immunology

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

1-6

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

The regulatory role of Valpha14 NKT cells in innate and acquired immune response.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

CD1 recognition by mouse NK1+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Sequence and expression of transcripts of the T-cell antigen receptor alpha-chain gene in a functional, antigen-specific suppressor-T-cell hybridoma

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Homogenous junctional sequence of the V14+ T-cell antigen receptor alpha chain expanded in unprimed mice

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Positive selection of invariant V alpha 14+ T cells by non-major histocompatibility complex-encoded class I-like molecules expressed on bone marrow-derived cells

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocytes

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Germline-encoded recognition of diverse glycolipids by natural killer T cells

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Differential Recognition of CD1d-α-Galactosyl Ceramide by the Vβ8.2 and Vβ7 Semi-invariant NKT T Cell Receptors

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Clinical applications of natural killer T cell-based immunotherapy for cancer

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Lysosomal glycosphingolipid recognition by NKT cells

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Requirement for natural killer T (NKT) cells in the induction of allograft tolerance

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Regulation of type 1 diabetes by NKT cells.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Valpha14 NK T cell-triggered IFN-gamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

The roles of TLRs, RLRs and NLRs in pathogen recognition

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Mechanism of CD1d-restricted natural killer T cell activation during microbial infection.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Regulation of antitumour immunity by CD1d-restricted NKT cells

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2FDXP104

21 January 2018

Identifiers

10.1093/INTIMM/DXP104

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37621786&oldid=2163673893"